173 related articles for article (PubMed ID: 37053020)
1. Long noncoding RNA POU6F2-AS2 contributes to the aggressiveness of nonsmall-cell lung cancer via microRNA-125b-5p-mediated E2F3 upregulation.
Yang H; Feng X; Tong X
Aging (Albany NY); 2023 Apr; 15(7):2689-2704. PubMed ID: 37053020
[TBL] [Abstract][Full Text] [Related]
2. Knockdown SNHG20 Suppresses Nonsmall Cell Lung Cancer Development by Repressing Proliferation, Migration and Invasion, and Inducing Apoptosis by Regulating miR-2467-3p/E2F3.
Chen H; Tan X; Ding Y
Cancer Biother Radiopharm; 2021 May; 36(4):360-370. PubMed ID: 32456448
[No Abstract] [Full Text] [Related]
3. Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p.
Shen D; Li J; Tao K; Jiang Y
Bioengineered; 2021 Dec; 12(1):3525-3538. PubMed ID: 34346845
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
Wang H; Wang L; Zhang S; Xu Z; Zhang G
Biomed Pharmacother; 2020 Jul; 127():110214. PubMed ID: 32403047
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
6. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
Ren P; Hong X; Chang L; Xing L; Zhang H
Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
[TBL] [Abstract][Full Text] [Related]
7. LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma.
Jin Y; Cao J; Cheng H; Hu X
J Chemother; 2023 Nov; 35(7):638-652. PubMed ID: 36797828
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA POU6F2-AS2 promotes cell proliferation and drug resistance in colon cancer by regulating miR-377/BRD4.
Xu G; Zhu H; Xu J; Wang Y; Zhang Y; Zhang M; Zhu D
J Cell Mol Med; 2020 Apr; 24(7):4136-4149. PubMed ID: 32100443
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA POU3F3 enhances cancer cell proliferation, migration and invasion in non-small cell lung cancer (adenocarcinoma) by downregulating microRNA-30d-5p.
Zeng Q; Dai Y; Duan C; Zeng R; Zeng Q; Wei C
BMC Pulm Med; 2020 Jul; 20(1):185. PubMed ID: 32615948
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p.
Liu Y; Lin X; Zhou S; Zhang P; Shao G; Yang Z
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064819
[No Abstract] [Full Text] [Related]
11. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
Wu X; Kong C; Wu Y
Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
[TBL] [Abstract][Full Text] [Related]
12. CTBP1-AS2 promoted non-small cell lung cancer progression via sponging the miR-623/MMP3 axis.
Yang G; Zhang C
Environ Sci Pollut Res Int; 2022 May; 29(25):38385-38394. PubMed ID: 35076836
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG12 Decreases Non-Small Cell Lung Cancer Cell Sensitivity to Cisplatin by Repressing miR-525-5p and Promoting XIAP.
Tan D; Wang S; Zhang P; Peng C; Wu T
Ann Clin Lab Sci; 2023 Jan; 53(1):64-75. PubMed ID: 36889771
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated
Sui J; Zhao Q; Zhang Y; Liang G
DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MEG8 promotes tumor progression of non-small cell lung cancer via regulating miR-107/CDK6 axis.
Liu Y; Li L; Shang P; Song X
Anticancer Drugs; 2020 Nov; 31(10):1065-1073. PubMed ID: 32649368
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
Wang YG; Wang T; Shi M; Zhai B
J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑433 reduces cell proliferation and invasion in non‑small cell lung cancer via directly targeting E2F transcription factor 3.
Liu N; Liu Z; Zhang W; Li Y; Cao J; Yang H; Li X
Mol Med Rep; 2018 Jul; 18(1):1155-1164. PubMed ID: 29767254
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
[TBL] [Abstract][Full Text] [Related]
19. LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
Wang L; Tang L; Ge T; Zhu F; Liu D; Guo H; Qian P; Xu N
BMC Pulm Med; 2021 Aug; 21(1):277. PubMed ID: 34454450
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
Guo R; Hu T; Liu Y; He Y; Cao Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]